Profile: Applied Genomics, Inc. develops & delivers tools useful for the detection and classification of human cancer. Our mammostrat is an immunohistochemistry breast cancer prognostic test that classifies an individual as having a high, moderate, and low risk of breast cancer recurrence. We offer mammostrat test for postmenopausal and node-negative estrogen receptor expressing breast cancer patients. Our Pulmotype™ is a five antibody immunohistochemistry aid for the classification of non-small cell lung cancer into adenocarcinoma versus squamous cell carcinoma subtypes.